We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-19.65%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$79.5M
AUM Growth
-$129M
Cap. Flow
+$5.75M
Cap. Flow %
7.23%
Top 10 Hldgs %
61.99%
Holding
120
New
40
Increased
18
Reduced
24
Closed
32

Top Buys

Rank Stock Value
1
SHIP icon
Seanergy Maritime Holdings
SHIP
+$3.88M
2
ATNM icon
Actinium Pharmaceuticals
ATNM
+$2.79M
3
SLS icon
SELLAS Life Sciences
SLS
+$2.79M
4
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$2.78M
5
RDGT
Ridgetech Inc
RDGT
+$2.6M

Top Sells

Rank Stock Value
1
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$2.41M
2
BCLI
BRAINSTORM CELL THERAPUTC
BCLI
+$2.28M
3
LOOP icon
Loop Industries
LOOP
+$1.97M
4
BIIB icon
Biogen
BIIB
+$1.62M
5
ORMP icon
Oramed Pharmaceuticals
ORMP
+$1.15M

Sector Composition

Rank Sector Weight
1 Healthcare 36.62%
2 Industrials 1.78%
3 Technology 1.66%
4 Consumer Discretionary 1.42%
5 Real Estate 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNKD icon
101
PUT
MannKind Corp
MNKD
$1.21B
– –
-2,018
Closed -$398K
NVAX icon
102
CALL
Novavax
NVAX
$1.21B
– –
-8
Closed -$8K
NVAX icon
103
Novavax
NVAX
$1.21B
– –
-43,000
Closed -$474K
NVAX icon
104
PUT
Novavax
NVAX
$1.21B
– –
-430
Closed -$474K
OCGN icon
105
Ocugen
OCGN
$420M
– –
-31,668
Closed -$220K
PALI icon
106
Palisade Bio
PALI
$351M
– –
-3
Closed -$106K
PLUR icon
107
PUT
Pluri
PLUR
$18.1M
– –
-3
Closed -$23K
USIO icon
108
Usio Inc
USIO
$53.8M
– –
-73,773
Closed -$193K
VTVT icon
109
vTv Therapeutics
VTVT
$122M
– –
-5,579
Closed -$382K
HURA
110
TuHURA Biosciences
HURA
$136M
– –
-28
Closed -$243K
KA
111
CALL
DELISTED
Kineta, Inc. Common Stock
KA
– –
-2
Closed -$28K
KA
112
DELISTED
Kineta, Inc. Common Stock
KA
– –
-221
Closed -$39K
NXTP
113
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
– –
-1,799
Closed -$73K
NOVN
114
DELISTED
Novan, Inc. Common Stock
NOVN
– –
-8,623
Closed -$82K
HMTV
115
DELISTED
Hemisphere Media Group, Inc.
HMTV
– –
-708,417
Closed -$113K
NSPRZ
116
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
– –
-1,067,324
Closed -$1K
PHIOW
117
DELISTED
Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
– –
-194,959
Closed -$5K
BLPH
118
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
– –
-20,594
Closed -$202K
TRNX
119
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
– –
-144,320
Closed -$459K
AKAO
120
PUT
DELISTED
Achaogen Inc
AKAO
– –
-136
Closed -$6K
1 2 3 4
5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q2 2019 Portfolio in Review

As of Q2 2019, Sabby Management held 120 positions worth $79.5M, down 62% from $208M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Sabby Management deployed $5.75M of net new capital in Q2 2019, opening 40 new positions and adding to 18 existing holdings. Its largest new stake was Seanergy Maritime Holdings: 10,437 shares worth $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 11% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Odonate Therapeutics, Inc. Common Stock, an estimated $2.41M trimmed.

  • Sabby Management's largest Q2 2019 buy was Seanergy Maritime Holdings: 10,437 shares worth $1.03M.
  • Sabby Management added most to Bridgeline Digital in Q2 2019, an estimated $625K increase.
  • Sabby Management's biggest Q2 2019 reduction was Odonate Therapeutics, Inc. Common Stock, cutting an estimated $2.41M.
  • Sabby Management fully exited Loop Industries in Q2 2019, selling an estimated $1.97M.
  • Sabby Management's ten largest holdings make up 62% of its $79.5M portfolio in Q2 2019.
  • Sabby Management opened 40 new positions and closed 32 in Q2 2019.
  • Sabby Management's portfolio value fell 62% quarter-over-quarter to $79.5M.

Based on Sabby Management's 13F filing for Q2 2019, filed 14 Aug 2019.